Abstract:RNA quality control is crucial for proper regulation of gene expression. Disruption of nonsense mediated mRNA decay (NMD), the primary RNA decay pathway responsible for the degradation of transcripts containing premature termination codons (PTCs), can disrupt development and lead to multiple diseases in humans and other animals. Similarly, therapies targeting NMD may have applications in hematological, neoplastic and neurological disorders. As such, tools capable of accurately quantifying NMD status could be invaluable for investigations of disease pathogenesis and biomarker identification. Toward this end, we assemble, validate, and apply a next-generation sequencing approach (NMDq) for identifying and measuring the abundance of PTC-containing transcripts. After validating NMDq performance and confirming its utility for tracking RNA surveillance, we apply it to determine pathway activity in two neurodegenerative diseases, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) characterized by RNA misprocessing and abnormal RNA stability. Despite the genetic and pathologic evidence implicating dysfunctional RNA metabolism, and NMD in particular, in these conditions, we detected no significant differences in PTC-encoding transcripts in ALS models or disease. Contrary to expectations, overexpression of the master NMD regulator UPF1 had little effect on the clearance of transcripts with PTCs, but rather restored RNA homeostasis through differential use and decay of alternatively poly-adenylated isoforms. Together, these data suggest that canonical NMD is not a significant contributor to ALS/FTD pathogenesis, and that UPF1 promotes neuronal survival by regulating transcripts with abnormally long 3’UTRs.

Rapid UPF1 depletion illuminates the temporal dynamics of the NMD-regulated transcriptome in human cells

Structural and Functional Insights into the Human Upf1 Helicase Core

Upf proteins: highly conserved factors involved in nonsense mRNA mediated decay

UPF1 helicase orchestrates mutually exclusive interactions with the SMG6 endonuclease and UPF2

Counter-regulation of RNA stability by UPF1 and TDP43

UPF1 ATPase autoinhibition and activation modulate RNA binding kinetics and NMD efficiency

NMD-degradome sequencing reveals ribosome-bound intermediates with 3′-end non-templated nucleotides

Dynamic RNA binding and unfolding by nonsense-mediated mRNA decay factor UPF2

Identification of an evolutionary conserved binding motif responsible for the recruitment of NMD factors to the UPF1 helicase

Divergent effects of translation termination factor eRF3A and nonsense-mediated mRNA decay factor UPF1 on the expression of uORF carrying mRNAs and ribosome protein genes

Structure of the Nmd4-Upf1 complex supports conservation of the nonsense-mediated mRNA decay pathway between yeast and humans

Regulation of non‐canonical proteins from diverse origins through the nonsense‐mediated mRNA decay pathway

NMD monitors translational fidelity 24/7

Genome-wide analysis of mRNAs regulated by the nonsense-mediated and 5' to 3' mRNA decay pathways in yeast.

Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways

SMG1:SMG8:SMG9-complex integrity maintains robustness of nonsense-mediated mRNA decay

UPF1 regulates mRNA stability by sensing poorly translated coding sequences

UPF3A is dispensable for nonsense-mediated mRNA decay in mouse pluripotent and somatic cells

Up-Frameshift Protein UPF1 Regulates Neurospora Crassa Circadian and Diurnal Growth Rhythms.

Nonsense Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells with SF3B1 and U2AF1 Mutations

NMD is required for timely cell fate transitions by fine-tuning gene expression and regulating translation